VINC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.60%

Insider Buying (Last 12 Months): $26,030.00

Insider Selling (Last 12 Months): $0.00

Vincerx Pharma Insider Trading History Chart

Vincerx Pharma Share Price & Price History

^$0.76

▼ -0.1366 (-15.23%)

As of 04/26/2024 04:28 PM ET

Days: 30 | 90 | 365

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

Vincerx Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/11/2023	Alexander A. Seelenberger	Insider	Buy	10,500	$0.95	$9,975.00	30,280
8/9/2023	Ahmed Hamdy	Insider	Buy	16,900	$0.95	$16,055.00	90,660
12/14/2022	Ahmed Hamdy	CEO	Buy	35,280	$0.87	$30,693.60	73,760
12/14/2022	Raquel E. Izumi	Insider	Buy	28,738	$0.88	$25,289.44	68,738
8/24/2022	Christopher P Lowe	Director	Buy	18,400	$1.65	$30,360.00	28,400
6/27/2022	Raquel E. Izumi	Insider	Buy	40,000	$1.41	$56,400.00	40,000
6/23/2022	Ahmed Hamdy	CEO	Buy	24,200	$1.41	$34,122.00	38,480
6/9/2022	Laura I. Bushnell	Director	Buy	15,000	$1.91	$28,650.00	19,202
12/22/2021	Ahmed Hamdy	CEO	Buy	6,450	$10.02	$64,629.00
12/22/2021	Alexander A. Seelenberger	CFO	Buy	2,417	$10.34	$24,991.78
12/22/2021	Laura I. Bushnell	Director	Buy	2,402	$10.48	$25,172.96
12/22/2021	Tom C. Thomas	Insider	Buy	1,000	$10.23	$10,230.00
8/4/2021	Raquel E. Izumi	Insider	Buy	1,000	$11.96	$11,960.00
6/29/2021	Andrew I. McDonald	Director	Buy	20,000	$12.38	$247,600.00	20,000
6/29/2021	Tom C. Thomas	Insider	Buy	2,000	$12.58	$25,160.00	205,522

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Secure Your Spot Now

SEC Filings (Institutional Ownership Changes) for Vincerx Pharma (NASDAQ:VINC)

44.02% of Vincerx Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vincerx Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Sabby Management LLC	57,353	$58K	0.0%	-44.4%	0.268%
10/26/2023	Sage Rhino Capital LLC	1,703,413	$1.72M	0.4%	+1.0%	7.967%
8/11/2023	Rubric Capital Management LP	354,377	$0.46M	0.0%	-8.4%	1.658%
8/11/2023	Tejara Capital Ltd	233,348	$0.30M	0.1%	-19.8%	1.091%
8/11/2023	ExodusPoint Capital Management LP	426,472	$0.55M	0.0%	+8.9%	1.995%
5/12/2023	Long Focus Capital Management LLC	545,352	$0.57M	0.1%	-61.5%	2.567%
5/12/2023	Tejara Capital Ltd	290,882	$0.30M	0.2%	-6.4%	1.369%
2/15/2023	Tang Capital Management LLC	101,762	$0.10M	0.0%	-90.1%	0.480%
2/1/2023	Sage Rhino Capital LLC	1,686,937	$1.72M	0.5%	+1.7%	7.961%
11/15/2022	Long Focus Capital Management LLC	1,061,505	$1.47M	0.1%	+8.3%	5.009%
11/10/2022	ExodusPoint Capital Management LP	172,302	$0.24M	0.0%	+72.1%	0.813%
11/4/2022	Russell Investments Group Ltd.	206,224	$0.28M	0.0%	N/A	0.973%
8/15/2022	Clearline Capital LP	452,184	$0.60M	0.1%	+9.6%	2.147%
7/28/2022	Sage Rhino Capital LLC	1,658,199	$2.19M	0.8%	+2.5%	7.874%
5/16/2022	Clearline Capital LP	412,657	$1.65M	0.2%	+215.4%	1.960%
5/5/2022	Russell Investments Group Ltd.	226,931	$0.91M	0.0%	+257.7%	1.078%
2/15/2022	Rubric Capital Management LP	1,586,245	$16.16M	0.8%	+20.9%	7.533%
2/15/2022	Schonfeld Strategic Advisors LLC	292,477	$2.98M	0.0%	+8.0%	1.389%
2/15/2022	Kingdon Capital Management L.L.C.	385,000	$3.92M	0.5%	+26.3%	1.828%
2/14/2022	Clearline Capital LP	130,856	$1.33M	0.1%	N/A	0.621%
2/14/2022	Long Focus Capital Management LLC	140,203	$1.43M	0.2%	N/A	0.666%
2/14/2022	Affinity Asset Advisors LLC	1,135,365	$11.57M	4.2%	+13.0%	5.392%
2/8/2022	Northern Trust Corp	143,530	$1.46M	0.0%	+19.2%	0.682%
1/28/2022	Allspring Global Investments Holdings LLC	8,151	$83K	0.0%	N/A	0.039%
1/21/2022	Russell Investments Group Ltd.	63,450	$0.64M	0.0%	+12.3%	0.301%
1/7/2022	Hollencrest Capital Management	10,000	$0.10M	0.0%	N/A	0.048%
12/29/2021	Hudson Bay Capital Management LP	200,000	$3.01M	0.0%	N/A	0.951%
11/16/2021	Schonfeld Strategic Advisors LLC	270,822	$4.38M	0.0%	+24.0%	1.288%
11/16/2021	Wellington Management Group LLP	332,917	$5.38M	0.0%	-63.7%	1.584%
11/16/2021	Citadel Advisors LLC	626,182	$10.13M	0.0%	-1.6%	2.979%
11/15/2021	Point72 Asset Management L.P.	344,827	$5.14M	0.0%	N/A	1.640%
11/15/2021	Deerfield Management Company L.P. Series C	1,379,310	$22.30M	0.4%	N/A	6.562%
11/15/2021	Pura Vida Investments LLC	59,809	$0.97M	0.0%	-72.1%	0.285%
11/15/2021	Rock Springs Capital Management LP	800,295	$12.94M	0.3%	N/A	3.807%
11/15/2021	Marshall Wace LLP	22,444	$0.36M	0.0%	-53.6%	0.107%
11/15/2021	Sphera Funds Management LTD.	654,572	$10.58M	0.9%	+187.8%	3.114%
11/15/2021	Kingdon Capital Management L.L.C.	304,896	$4.93M	0.6%	+49.9%	1.450%
11/15/2021	Hudson Bay Capital Management LP	200,000	$3.01M	0.0%	N/A	0.951%
11/12/2021	Affinity Asset Advisors LLC	1,005,000	$16.25M	4.1%	+19.9%	4.781%
11/12/2021	Renaissance Technologies LLC	30,600	$0.50M	0.0%	-55.7%	0.146%
11/12/2021	Rubric Capital Management LP	1,312,406	$21.22M	0.6%	+145.9%	6.243%
11/12/2021	Geode Capital Management LLC	217,798	$3.52M	0.0%	+44.5%	1.036%
11/9/2021	BlackRock Inc.	728,091	$11.77M	0.0%	+123.2%	3.464%
11/9/2021	Monashee Investment Management LLC	200,000	$3.23M	0.6%	+307.7%	0.951%
11/8/2021	Russell Investments Group Ltd.	56,516	$0.91M	0.0%	-5.4%	0.269%
11/4/2021	Deutsche Bank AG	7,504	$0.12M	0.0%	+168.7%	0.036%
11/2/2021	New York State Common Retirement Fund	4,746	$77K	0.0%	-46.7%	0.023%
10/22/2021	Strs Ohio	3,000	$48K	0.0%	+172.7%	0.014%
8/25/2021	Marshall Wace LLP	48,366	$0.63M	0.0%	N/A	0.276%
8/18/2021	Ikarian Capital LLC	426,743	$5.54M	0.4%	-2.7%	2.436%
8/17/2021	Sphera Funds Management LTD.	227,450	$2.96M	0.2%	+142.7%	1.298%
8/17/2021	Millennium Management LLC	51,043	$0.66M	0.0%	-34.7%	0.291%
8/17/2021	Acuta Capital Partners LLC	478,401	$6.21M	2.5%	+21.4%	2.730%
8/17/2021	Boothbay Fund Management LLC	54,283	$0.71M	0.0%	+18.1%	0.310%
8/17/2021	Boxer Capital LLC	450,000	$5.85M	0.2%	N/A	2.568%
8/17/2021	Citadel Advisors LLC	636,144	$8.26M	0.0%	+47.9%	3.631%
8/16/2021	California State Teachers Retirement System	6,445	$84K	0.0%	N/A	0.037%
8/16/2021	Putnam Investments LLC	221,035	$2.87M	0.0%	-55.8%	1.262%
8/16/2021	Schonfeld Strategic Advisors LLC	218,367	$2.84M	0.0%	+3.1%	1.246%
8/16/2021	Charles Schwab Investment Management Inc.	17,202	$0.22M	0.0%	N/A	0.098%
8/16/2021	State Street Corp	83,627	$1.09M	0.0%	N/A	0.477%
8/16/2021	Kingdon Capital Management L.L.C.	203,418	$2.64M	0.3%	N/A	1.161%
8/16/2021	Sabby Management LLC	271,063	$3.52M	0.5%	+226.8%	1.547%
8/16/2021	Marshall Wace LLP	48,366	$0.63M	0.0%	N/A	0.276%
8/16/2021	Shay Capital LLC	11,361	$0.15M	0.0%	N/A	0.065%
8/13/2021	RTW Investments LP	749,999	$9.74M	0.1%	+50.0%	4.281%
8/13/2021	Renaissance Technologies LLC	69,100	$0.90M	0.0%	N/A	0.394%
8/13/2021	Northern Trust Corp	64,141	$0.83M	0.0%	+256.8%	0.366%
8/13/2021	Altium Capital Management LP	107,625	$1.40M	0.3%	N/A	0.614%
8/13/2021	Affinity Asset Advisors LLC	838,311	$10.89M	3.9%	+54.4%	4.785%
8/13/2021	Murchinson Ltd.	29,037	$0.38M	0.1%	N/A	0.166%
8/13/2021	Jump Financial LLC	20,000	$0.26M	0.0%	N/A	0.114%
8/13/2021	Geode Capital Management LLC	150,772	$1.96M	0.0%	+60.5%	0.861%
8/13/2021	Vanguard Group Inc.	480,058	$6.24M	0.0%	+23.1%	2.740%
8/12/2021	JPMorgan Chase & Co.	7,036	$91K	0.0%	N/A	0.040%
8/12/2021	Bank of Montreal Can	252,902	$3.18M	0.0%	N/A	1.443%
8/12/2021	Monashee Investment Management LLC	49,053	$0.64M	0.1%	-50.9%	0.280%
8/11/2021	Bank of New York Mellon Corp	12,014	$0.16M	0.0%	N/A	0.069%
8/11/2021	BlackRock Inc.	326,234	$4.24M	0.0%	+259.5%	1.862%
8/11/2021	Deutsche Bank AG	2,793	$36K	0.0%	N/A	0.016%
8/4/2021	Creative Planning	35,000	$0.46M	0.0%	N/A	0.200%
8/4/2021	Russell Investments Group Ltd.	59,740	$0.78M	0.0%	N/A	0.341%
8/2/2021	New York State Common Retirement Fund	8,900	$0.12M	0.0%	N/A	0.051%
5/19/2021	Logos Global Management LP	480,000	$9.26M	0.9%	N/A	3.432%
5/18/2021	Millennium Management LLC	78,139	$1.51M	0.0%	N/A	0.559%
5/18/2021	Verition Fund Management LLC	50,406	$0.97M	0.0%	N/A	0.360%
5/18/2021	Tang Capital Management LLC	500,000	$9.65M	2.7%	N/A	3.576%
5/18/2021	Citadel Advisors LLC	430,227	$8.30M	0.0%	N/A	2.455%
5/18/2021	Holocene Advisors LP	595,533	$11.49M	0.1%	+61.3%	4.259%
5/17/2021	Schonfeld Strategic Advisors LLC	211,867	$4.09M	0.0%	+175.4%	1.515%
5/17/2021	Putnam Investments LLC	500,000	$9.65M	0.0%	N/A	3.576%
5/17/2021	Acuta Capital Partners LLC	394,000	$7.60M	2.7%	N/A	2.818%
5/17/2021	Sphera Funds Management LTD.	93,708	$1.81M	0.1%	+101.7%	0.670%
5/17/2021	Ikarian Capital LLC	438,684	$8.47M	0.3%	-18.6%	3.137%
5/14/2021	Monashee Investment Management LLC	99,999	$1.93M	0.3%	-50.0%	0.715%
5/14/2021	Credit Suisse AG	26,568	$0.51M	0.0%	N/A	0.190%
5/13/2021	Penserra Capital Management LLC	3,718	$71K	0.0%	N/A	0.027%
5/13/2021	Citigroup Inc.	4,683	$90K	0.0%	N/A	0.033%
5/12/2021	Northern Trust Corp	17,977	$0.35M	0.0%	N/A	0.129%
5/12/2021	Geode Capital Management LLC	93,959	$1.81M	0.0%	N/A	0.672%

Data available starting January 2016

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.

Today's Range

Now: $0.76

$0.76

$0.85

50 Day Range

MA: $4.09

$0.85

$8.06

52 Week Range

Now: $0.76

$0.61

$9.37

Volume

1,241,473 shs

Average Volume

1,250,404 shs

Market Capitalization

$16.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

Who are the company insiders with the largest holdings of Vincerx Pharma?: Vincerx Pharma's top insider investors include:
Ahmed Md Hamdy (Insider)
Ahmed Md Hamdy (CEO)
Raquel E Izumi (Insider)
Alexander A Seelenberger (Insider)
Christopher P Lowe (Director)
Laura I Bushnell (Director)
Learn More about top insider investors at Vincerx Pharma.